Birdwatch Note
2024-12-14 07:26:07 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
USAG-1 focuses on treating congenital tooth agenesis and is primarily aimed at people who are born without certain teeth due to developmental conditions. It does not specifically mention applications for people who have lost teeth later in life (eg due to injury or decay) https://pubmed.ncbi.nlm.nih.gov/39389160/
Written by E8FF2337AD571A8EEAACDCABAFEAC6EFCFA52F30A4108BDDCA275C5971957B13
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1867789654256152622
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1867833433033949589
- noteId - 1867833433033949589
- participantId -
- noteAuthorParticipantId - E8FF2337AD571A8EEAACDCABAFEAC6EFCFA52F30A4108BDDCA275C5971957B13 Participant Details
- createdAtMillis - 1734161167759
- tweetId - 1867789654256152622
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- USAG-1 focuses on treating congenital tooth agenesis and is primarily aimed at people who are born without certain teeth due to developmental conditions. It does not specifically mention applications for people who have lost teeth later in life (eg due to injury or decay) https://pubmed.ncbi.nlm.nih.gov/39389160/
Note Ratings
| rated at | rated by | |
| 2024-12-14 13:14:41 -0600 | Rating Details | |
| 2024-12-14 10:52:37 -0600 | Rating Details | |
| 2024-12-14 10:21:06 -0600 | Rating Details | |
| 2024-12-14 07:09:19 -0600 | Rating Details | |
| 2024-12-14 04:50:08 -0600 | Rating Details | |
| 2024-12-14 19:50:40 -0600 | Rating Details | |
| 2024-12-14 21:54:37 -0600 | Rating Details | |
| 2024-12-14 07:42:54 -0600 | Rating Details | |
| 2024-12-14 04:01:07 -0600 | Rating Details | |
| 2024-12-14 02:45:01 -0600 | Rating Details | |
| 2024-12-14 22:40:25 -0600 | Rating Details | |
| 2024-12-14 15:59:29 -0600 | Rating Details | |
| 2024-12-14 11:46:12 -0600 | Rating Details | |
| 2024-12-14 08:42:05 -0600 | Rating Details | |
| 2024-12-14 01:56:47 -0600 | Rating Details | |
| 2024-12-14 01:46:19 -0600 | Rating Details | |
| 2024-12-14 17:13:31 -0600 | Rating Details | |
| 2024-12-14 12:31:17 -0600 | Rating Details | |
| 2024-12-14 10:22:56 -0600 | Rating Details | |
| 2024-12-14 09:05:19 -0600 | Rating Details |